A selfreplicating RNA Precision Immunotherapeutic for Overcoming Resistance to Endocrine Therapy in Estrogen Receptor Positive Breast Cancer (ER plus BC)

被引:0
|
作者
Goldberg, Zelanna
Maine, Christian
Dailey, Gabrielle
Domingo, Christine
Picarda, Gaelle
Little, Hunter
Chou, Annie
Sparks, Jessica
Spasova, Darina
Miyake-Stoner, Shiegeki
Hartman, Zachary C.
Rabiola, Christopher
Crosby, Erika
Lyerly, Herbert
Wang, Nathaniel
Aliahmad, Parinaz
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO3-26-06
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO3-26-06
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [2] A self-replicating RNA precision medicine approach to overcoming resistance to endocrine therapy in ER plus BC
    Goldberg, Zelanna
    Maine, Christian
    Dailey, Gabrielle P.
    Domingo, Christine
    Picarda, Gaelle
    Little, Hunter
    Chou, Annie
    Sparks, Jessica
    Spasova, Darina
    Miyake-Stoner, Shigeki
    Hartman, Zachary C.
    Rabiola, Christopher A.
    Crosby, Erika J.
    Lyerly, Herbert K.
    Wang, Nathaniel
    Aliahmad, Parinaz
    CANCER RESEARCH, 2023, 83 (07)
  • [3] THE USE OF ADJUVANT ENDOCRINE THERAPY IN OLDER WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER (BC)
    Aapro, M.
    Crivellari, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 208 - 209
  • [4] PARP inhibition effects on endocrine therapy and resistance in estrogen receptor positive (ER plus ) breast cancer models
    Nardone, Agostina
    Goldstein, Amit
    Shea, Martin J.
    Mithchell, Tamika
    Fu, Xiaoyong
    De Angelis, Carmine
    Hu, Huizhong
    Xu, Xiaowei
    Rajendran, Mahitha
    O'Connor, Mark
    Locker, Gershon
    Hilsenbeck, Susan
    Osborne, Kent
    Schiff, Rachel
    CANCER RESEARCH, 2015, 75
  • [5] Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC) Has a Poor Response to Endocrine Therapy (ET)
    Guo, Tao
    Shen, Tiansheng
    Britt, Jacob
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2017, 30 : 44A - 44A
  • [6] Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC) Has a Poor Response to Endocrine Therapy (ET)
    Guo, Tao
    Shen, Tiansheng
    Britt, Jacob
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2017, 97 : 44A - 44A
  • [7] Identification of preclinical mechanisms driving acquired resistance to endocrine therapy in estrogen-receptor positive (ER plus ) breast cancer cells
    Ong, C.
    Daemen, A.
    Merrick, K.
    O'Brien, T.
    Friedman, L.
    Hatzivassiliou, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [8] Late disease recurrence in estrogen receptor positive (ER plus ) premenopausal breast cancer (BC)
    Recchia, Francesco
    Candeloro, Giampiero
    Necozione, Stefano
    Rea, Silvio
    Hoo, William Soo
    Cantor, Tom
    CANCER RESEARCH, 2014, 74 (19)
  • [9] The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
    Rodriguez, David
    Ramkairsingh, Marc
    Lin, Xiaozeng
    Kapoor, Anil
    Major, Pierre
    Tang, Damu
    CANCERS, 2019, 11 (07)
  • [10] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77